Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cartesian Therapeutics (RNAC) Interest & Investment Income: 2015-2025

Historic Interest & Investment Income for Cartesian Therapeutics (RNAC) over the last 11 years, with Sep 2025 value amounting to $1.5 million.

  • Cartesian Therapeutics' Interest & Investment Income fell 39.84% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year increase of 32.24%. This contributed to the annual value of $7.4 million for FY2024, which is 48.79% up from last year.
  • As of Q3 2025, Cartesian Therapeutics' Interest & Investment Income stood at $1.5 million, which was down 11.44% from $1.7 million recorded in Q2 2025.
  • In the past 5 years, Cartesian Therapeutics' Interest & Investment Income ranged from a high of $2.6 million in Q3 2024 and a low of $9,000 during Q4 2021.
  • Over the past 3 years, Cartesian Therapeutics' median Interest & Investment Income value was $1.4 million (recorded in 2023), while the average stood at $1.6 million.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first tumbled by 95.00% in 2021, then surged by 12,577.78% in 2022.
  • Over the past 5 years, Cartesian Therapeutics' Interest & Investment Income (Quarterly) stood at $9,000 in 2021, then spiked by 12,577.78% to $1.1 million in 2022, then declined by 17.62% to $940,000 in 2023, then surged by 161.06% to $2.5 million in 2024, then crashed by 39.84% to $1.5 million in 2025.
  • Its Interest & Investment Income was $1.5 million in Q3 2025, compared to $1.7 million in Q2 2025 and $2.0 million in Q1 2025.